Assessing BRAFV600E Expression in Malignant Melanoma

This cross-sectional study describes use of VE1 immunohistochemical analysis to assess the presence of BRAFV600E mutations in tumor specimens from patients with cutaneous malignant melanoma.

Source: JAMA Oncology - January 15, 2015 Category: Cancer & Oncology Authors: Hanna Eriksson, MD, PhD and colleagues Tags: JAMA Dermatology Original Investigation Research Source Type: research